Rigel Pharmaceuticals (RIGL) Interest Expenses (2010 - 2026)
Rigel Pharmaceuticals (RIGL) posted quarterly Interest Expenses of $2.4 million for Q1 2026, down 84.68% year-over-year from $15.3 million in Q1 2025, and down 61.91% quarter-over-quarter from $6.2 million in Q4 2025.
Rigel Pharmaceuticals (RIGL) Interest Expenses (2010 - 2026) Analysis & Trends
Rigel Pharmaceuticals' Interest Expenses history runs 17 years deep, the most recent figure standing at $2.4 million for Q1 2026.
- In Q1 2026, Interest Expenses fell 84.68% year-over-year to $2.4 million; the TTM figure through Mar 2026 stood at $2.4 million (down 84.68% YoY), while the FY2025 annual figure was $46.7 million, down 85.82% from the prior year.
- Interest Expenses for Q1 2026 stood at $2.4 million, down from $6.2 million in the prior quarter.
- The five-year high for Interest Expenses was $17.7 million in Q1 2024, with the low at -$4.1 million in Q4 2022.
- The 5-year median for Interest Expenses is $6.1 million (2022), against an average of $7.8 million.
- The sharpest annual moves came in 2022 and 2024: Interest Expenses tumbled 419.4% in 2022, then soared 1020.65% in 2024.
- Rigel Pharmaceuticals' Interest Expenses stood at -$4.1 million in 2022, then surged by 165.2% to $2.7 million in 2023, then declined by 2.92% to $2.6 million in 2024, then soared by 135.07% to $6.2 million in 2025, then slumped by 61.91% to $2.4 million in 2026.
- Business Quant data shows RIGL's Interest Expenses at $2.4 million in Q1 2026, $6.2 million in Q4 2025, and $15.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 439.40 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 52.50 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 2.70 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 39.74 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 335,572.77 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 218.10 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 82.05 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 20.27 Mn |
| 10 | Rigel Pharmaceuticals | 795.39 Mn | 700.06 Mn | 70.18 Mn | 7.06 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 779,000.00 |
| Jun 30, 2026 | 779,000.00 |
| Mar 31, 2026 | 2.35 Mn |
| Mar 31, 2026 | 2.35 Mn |
| Dec 31, 2025 | 6.17 Mn |
| Dec 31, 2025 | 6.17 Mn |
| Sep 30, 2025 | 15.35 Mn |
| Sep 30, 2025 | 15.35 Mn |
| Jun 30, 2025 | 15.35 Mn |
| Jun 30, 2025 | 15.35 Mn |
| Mar 31, 2025 | 15.35 Mn |
| Mar 31, 2025 | 15.35 Mn |
| Dec 31, 2024 | 2.63 Mn |
| Dec 31, 2024 | 2.63 Mn |
| Sep 30, 2024 | 17.70 Mn |
| Sep 30, 2024 | 17.70 Mn |
| Jun 30, 2024 | 17.70 Mn |
| Jun 30, 2024 | 17.70 Mn |
| Mar 31, 2024 | 17.70 Mn |
| Mar 31, 2024 | 17.70 Mn |